184 related articles for article (PubMed ID: 22149582)
1. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?
Bernardi M; Maggioli C; Dibra V; Zaccherini G
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):57-66. PubMed ID: 22149582
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Zambruni A; Trevisani F; Di Micoli A; Savelli F; Berzigotti A; Bracci E; Caraceni P; Domenicali M; Felline P; Zoli M; Bernardi M
J Hepatol; 2008 Mar; 48(3):415-21. PubMed ID: 18194821
[TBL] [Abstract][Full Text] [Related]
3. Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.
Theocharidou E; Krag A; Bendtsen F; Møller S; Burroughs AK
Liver Int; 2012 Oct; 32(9):1327-32. PubMed ID: 22292920
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of the heart to arrhythmia in response to QT-prolongation associated with unhomogeneous repolarization: further data concerning the pathomechanism of arrhythmias associated with long QT-syndrome.
Solti F; Czakó E; Juhász-Nagy S; Kékesi V; Szántó A; Oswald P
Acta Med Acad Sci Hung; 1982; 39(3-4):227-36. PubMed ID: 7185248
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced QT-interval prolongation: considerations for clinicians.
Li EC; Esterly JS; Pohl S; Scott SD; McBride BF
Pharmacotherapy; 2010 Jul; 30(7):684-701. PubMed ID: 20575633
[TBL] [Abstract][Full Text] [Related]
6. Long QT: good, bad or indifferent?
Surawicz B; Knoebel SB
J Am Coll Cardiol; 1984 Aug; 4(2):398-413. PubMed ID: 6145737
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological changes in patients with liver cirrhosis in a tertiary care hospital in Karachi, Pakistan.
Parkash O; Mohyuddin GR; Ayub A; Nazir I; Maan AA; Hamid S
J Ayub Med Coll Abbottabad; 2016; 28(4):676-679. PubMed ID: 28586578
[TBL] [Abstract][Full Text] [Related]
8. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors.
Bernardi M; Calandra S; Colantoni A; Trevisani F; Raimondo ML; Sica G; Schepis F; Mandini M; Simoni P; Contin M; Raimondo G
Hepatology; 1998 Jan; 27(1):28-34. PubMed ID: 9425913
[TBL] [Abstract][Full Text] [Related]
9. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis.
Trevisani F; Di Micoli A; Zambruni A; Biselli M; Santi V; Erroi V; Lenzi B; Caraceni P; Domenicali M; Cavazza M; Bernardi M
Liver Int; 2012 Nov; 32(10):1510-5. PubMed ID: 22776742
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of QT interval assessment in diabetes.
Veglio M; Chinaglia A; Cavallo Perin P
Diabetes Nutr Metab; 2000 Dec; 13(6):356-65. PubMed ID: 11232762
[TBL] [Abstract][Full Text] [Related]
11. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization.
Fossa AA; Wisialowski T; Crimin K
J Pharmacol Exp Ther; 2006 Feb; 316(2):498-506. PubMed ID: 16204470
[TBL] [Abstract][Full Text] [Related]
12. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
[TBL] [Abstract][Full Text] [Related]
13. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
14. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
Semrád B
Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
[TBL] [Abstract][Full Text] [Related]
15. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium.
Genovesi S; Prata Pizzala DM; Pozzi M; Ratti L; Milanese M; Pieruzzi F; Vincenti A; Stella A; Mancia G; Stramba-Badiale M
Clin Sci (Lond); 2009 May; 116(12):851-9. PubMed ID: 19076059
[TBL] [Abstract][Full Text] [Related]
16. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.
Mumford JL; Wu K; Xia Y; Kwok R; Yang Z; Foster J; Sanders WE
Environ Health Perspect; 2007 May; 115(5):690-4. PubMed ID: 17520054
[TBL] [Abstract][Full Text] [Related]
17. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
18. Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: the roles of nitric oxide and endogenous opioid peptides.
Tavakoli S; Hajrasouliha AR; Jabehdar-Maralani P; Ebrahimi F; Solhpour A; Sadeghipour H; Ghasemi M; Dehpour AR
J Hepatol; 2007 Mar; 46(3):432-9. PubMed ID: 17125877
[TBL] [Abstract][Full Text] [Related]
19. QT Interval Prolongation and QRS Voltage Reduction in Patients with Liver Cirrhosis.
Cichoż-Lach H; Tomaszewski M; Kowalik A; Lis E; Tomaszewski A; Lach T; Boczkowska S; Celiński K
Adv Clin Exp Med; 2015; 24(4):615-22. PubMed ID: 26469105
[TBL] [Abstract][Full Text] [Related]
20. Short QT Syndrome: a familial cause of sudden death.
Gaita F; Giustetto C; Bianchi F; Wolpert C; Schimpf R; Riccardi R; Grossi S; Richiardi E; Borggrefe M
Circulation; 2003 Aug; 108(8):965-70. PubMed ID: 12925462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]